about
Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study.Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9.Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.miRNA regulation of LDL-cholesterol metabolism.Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice.Association of trace metal elements with lipid profiles in type 2 diabetes mellitus patients: a cross sectional study.Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production.mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion.A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.Methionine-supplemented diet affects the expression of cardiovascular disease-related genes and increases inflammatory cytokines in mice heart and liver.Nutraceutical approaches to metabolic syndrome.Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study.Alleviating VLDL overproduction is an important mechanism for Laminaria japonica polysaccharide to inhibit atherosclerosis in LDLr-/- mice with diet-induced insulin resistance.Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study.Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile.Association between insulin resistance and the development of cardiovascular disease
P2860
Q33858526-00D0EDB2-9EE4-4F07-8A1A-9A679F907839Q33858997-8A7B8FD9-B2C2-4CD2-9F4B-4A70538E13C6Q33940346-9F898A32-B83E-40A8-B2FB-8FFF89AF3D40Q34480492-C0E285C0-D875-4779-9965-0A1DE77023E4Q35794774-46FBBEFF-1E99-464A-9D6E-A4471B5FFE3AQ37705810-9823DE4B-37BE-4968-AF7F-AC59C8E1AB9CQ38770213-4B7AF956-DA0F-4FD3-9A48-5A1E4C8FD00BQ38796312-75476139-18DA-4508-A32C-F55E7F5DA59FQ41705191-60CB5DD2-8C48-4D4E-A837-FF05A7A0C9E1Q42377426-286E4FDB-E112-471A-87F9-5DF5FB9832AEQ42395469-4B453225-8DAD-4629-B743-66403A1B9D9BQ47649038-3E26B046-95A8-4BE5-AE8E-6B4E1998DFA5Q47744240-405D6697-EE94-4AD3-B4E2-6B9CA471EAD9Q47842760-EDC2B984-E9AB-4625-9891-37D6B9617EB4Q47979569-37DA0D69-4EA6-4007-8E4D-B8CDC000A078Q48329929-A12E2A59-5144-41A0-AFDD-39AED28C458DQ51084242-A0711488-6774-4AF3-929F-A0D6632FCFB2Q55398375-21A031C7-8FB3-4FA9-9B0D-B561A29F97F5Q55416101-56E289A8-94EB-4249-B68D-E36B7352DD1DQ58782220-6F3211C3-D087-4A90-BC6D-2A69008E0C2B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The regulation of ApoB metabolism by insulin.
@en
type
label
The regulation of ApoB metabolism by insulin.
@en
prefLabel
The regulation of ApoB metabolism by insulin.
@en
P2093
P2860
P1476
The regulation of ApoB metabolism by insulin.
@en
P2093
Alan D Attie
Mary E Haas
Sudha B Biddinger
P2860
P304
P356
10.1016/J.TEM.2013.04.001
P577
2013-05-27T00:00:00Z